Bipolar disorder - new drugs (TA66) (replaced by CG38)
The clinical effectiveness and cost effectiveness of new drugs for bipolar disorder
This guidance has been replaced by CG38 Bipolar disorder
This page was last updated: 20 December 2011
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.